Myriad Genetics Inc
NASDAQ:MYGN
Myriad Genetics Inc
NASDAQ:MYGN
Price:
22.955 USD
2.2%
Market Closed
Updated:
Jun 1, 2024
Myriad Genetics Inc
Common Shares Outstanding
|
Myriad Genetics Inc
Common Shares Outstanding Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Myriad Genetics Inc
NASDAQ:MYGN
|
Common Shares Outstanding
$90.5m
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Common Shares Outstanding
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Common Shares Outstanding
$1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Common Shares Outstanding
$536.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Common Shares Outstanding
$258.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Common Shares Outstanding
$110.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Myriad Genetics Inc's Common Shares Outstanding?
Common Shares Outstanding
90.5m
USD
90.5m
USD
Based on the financial report for Mar 31, 2024, Myriad Genetics Inc's Common Shares Outstanding amounts to 90.5m USD.
What is Myriad Genetics Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
2%
2%
Over the last year, the Common Shares Outstanding growth was 11%. The average annual Common Shares Outstanding growth rates for Myriad Genetics Inc have been 6% over the past three years , 4% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet
